Showing results (101-110 of 314) with videos related to

Sort By:
Pageof 32
Annals of the Rheumatic Diseases|January 10, 2023
Influence of active versus placebo control on treatment responses in randomised controlled trials in rheumatoid arthritisAndreas Kerschbaumer, Nina Maria Stimakovits, Josef S Smolen, et al.
Arthritis Research & Therapy|March 2, 2006
Methotrexate in rheumatoid arthritis is frequently effective, even if re-employed after a previous failureTheresa Kapral, Tanja Stamm, Klaus P Machold, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 27, 2023
Association between reactogenicity and immunogenicity after BNT162b2 booster vaccination: a secondary analysis of a prospective cohort studyAnselm Jorda, Felix Bergmann, Robin Ristl, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2016
Brief Report: Remission Rates With Tofacitinib Treatment in Rheumatoid Arthritis: A Comparison of Various Remission CriteriaJosef S Smolen, Daniel Aletaha, David Gruben, et al.
Annals of the Rheumatic Diseases|September 1, 2009
Estimation of a numerical value for joint damage-related physical disability in rheumatoid arthritis clinical trialsJosef S Smolen, Daniel Aletaha, Johannes C Grisar, et al.
Rheumatology (Oxford, England)|February 27, 2018
Early response to therapy predicts 6-month and 1-year disease activity outcomes in psoriatic arthritis patientsMonika M Schoels, Uriel Landesmann, Farideh Alasti, et al.
Annals of the Rheumatic Diseases|September 28, 2013
Proposal for a new nomenclature of disease-modifying antirheumatic drugsJosef S Smolen, Désirée van der Heijde, Klaus P Machold, et al.
Rheumatology (Oxford, England)|July 4, 2023
The influence of biological DMARDs on aseptic arthroplasty loosening: a retrospective cohort studyMarkus M Schreiner, Jennifer Straub, Sebastian Apprich, et al.
Arthritis Research & Therapy|November 12, 2019
Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trialsJosef Smolen, Roy Fleischmann, Daniel Aletaha, et al.
Rheumatology and Therapy|November 26, 2024
The Uncoupling of Disease Activity from Joint Structural Progression in Patients with Rheumatoid Arthritis Treated with FilgotinibYoshiya Tanaka, Tatsuya Atsumi, Daniel Aletaha, et al.
Pageof 32